Report Detail
Global (United States, European Union and China) Q Fever Market Research Report 2019-2025
- RnM3650408 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Chemical & Material
Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases.
In 2019, the market size of Q Fever is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Q Fever.
This report studies the global market size of Q Fever, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Q Fever production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (U.S.)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS, INC. (U.S.)
Pfizer (U.S.)
Cipla Inc. (India)
Market Segment by Product Type
Acute Q Fever
Chronic Q Fever
Market Segment by Application
Hospitals & Clinics
Diagnostic Centers
Surgical Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Q Fever status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Q Fever manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Q Fever are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Q Fever Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Acute Q Fever
- 1.3.3 Chronic Q Fever
- 1.4 Market Segment by Application
- 1.4.1 Global Q Fever Market Share by Application (2019-2025)
- 1.4.2 Hospitals & Clinics
- 1.4.3 Diagnostic Centers
- 1.4.4 Surgical Centers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Q Fever Production Value 2014-2025
- 2.1.2 Global Q Fever Production 2014-2025
- 2.1.3 Global Q Fever Capacity 2014-2025
- 2.1.4 Global Q Fever Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Q Fever Market Size CAGR of Key Regions
- 2.2.2 Global Q Fever Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Q Fever Capacity by Manufacturers
- 3.1.2 Global Q Fever Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Q Fever Revenue by Manufacturers (2014-2019)
- 3.2.2 Q Fever Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Q Fever Market Concentration Ratio (CR5 and HHI)
- 3.3 Q Fever Price by Manufacturers
- 3.4 Key Manufacturers Q Fever Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Q Fever Market
- 3.6 Key Manufacturers Q Fever Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Acute Q Fever Production and Production Value (2014-2019)
- 4.1.2 Chronic Q Fever Production and Production Value (2014-2019)
- 4.2 Global Q Fever Production Market Share by Type
- 4.3 Global Q Fever Production Value Market Share by Type
- 4.4 Q Fever Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Q Fever Consumption by Application
6 Production by Regions
- 6.1 Global Q Fever Production (History Data) by Regions 2014-2019
- 6.2 Global Q Fever Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Q Fever Production Growth Rate 2014-2019
- 6.3.2 United States Q Fever Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Q Fever Import & Export
- 6.4 European Union
- 6.4.1 European Union Q Fever Production Growth Rate 2014-2019
- 6.4.2 European Union Q Fever Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Q Fever Import & Export
- 6.5 China
- 6.5.1 China Q Fever Production Growth Rate 2014-2019
- 6.5.2 China Q Fever Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Q Fever Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Q Fever Consumption by Regions
- 7.1 Global Q Fever Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Q Fever Consumption by Type
- 7.2.2 United States Q Fever Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Q Fever Consumption by Type
- 7.3.2 European Union Q Fever Consumption by Application
- 7.4 China
- 7.4.1 China Q Fever Consumption by Type
- 7.4.2 China Q Fever Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Q Fever Consumption by Type
- 7.5.2 Rest of World Q Fever Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Yashica Pharmaceuticals Private Limited (India)
- 8.1.1 Yashica Pharmaceuticals Private Limited (India) Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Q Fever
- 8.1.4 Q Fever Product Introduction
- 8.1.5 Yashica Pharmaceuticals Private Limited (India) Recent Development
- 8.2 Merck & Co. (U.S.)
- 8.2.1 Merck & Co. (U.S.) Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Q Fever
- 8.2.4 Q Fever Product Introduction
- 8.2.5 Merck & Co. (U.S.) Recent Development
- 8.3 Atox Bio (Israel)
- 8.3.1 Atox Bio (Israel) Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Q Fever
- 8.3.4 Q Fever Product Introduction
- 8.3.5 Atox Bio (Israel) Recent Development
- 8.4 Teva Pharmaceutical Industries (Israel)
- 8.4.1 Teva Pharmaceutical Industries (Israel) Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Q Fever
- 8.4.4 Q Fever Product Introduction
- 8.4.5 Teva Pharmaceutical Industries (Israel) Recent Development
- 8.5 Basilea Pharmaceutica Ltd. (Switzerland)
- 8.5.1 Basilea Pharmaceutica Ltd. (Switzerland) Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Q Fever
- 8.5.4 Q Fever Product Introduction
- 8.5.5 Basilea Pharmaceutica Ltd. (Switzerland) Recent Development
- 8.6 MELINTA THERAPEUTICS, INC. (U.S.)
- 8.6.1 MELINTA THERAPEUTICS, INC. (U.S.) Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Q Fever
- 8.6.4 Q Fever Product Introduction
- 8.6.5 MELINTA THERAPEUTICS, INC. (U.S.) Recent Development
- 8.7 Pfizer (U.S.)
- 8.7.1 Pfizer (U.S.) Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Q Fever
- 8.7.4 Q Fever Product Introduction
- 8.7.5 Pfizer (U.S.) Recent Development
- 8.8 Cipla Inc. (India)
- 8.8.1 Cipla Inc. (India) Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Q Fever
- 8.8.4 Q Fever Product Introduction
- 8.8.5 Cipla Inc. (India) Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Q Fever Capacity, Production Forecast 2019-2025
- 9.1.2 Global Q Fever Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Q Fever Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Q Fever Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Q Fever Production Forecast by Type
- 9.7.2 Global Q Fever Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Q Fever Sales Channels
- 10.2.2 Q Fever Distributors
- 10.3 Q Fever Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Q Fever. Industry analysis & Market Report on Q Fever is a syndicated market report, published as Global (United States, European Union and China) Q Fever Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Q Fever market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
